<?xml version='1.0' encoding='utf-8'?>
<document id="23312127"><sentence text="Drug-drug interactions contributing to QT prolongation in cardiac intensive care units." /><sentence text="To determine the most common drug-drug interaction (DDI) pairs contributing to QTc prolongation in cardiac intensive care units (ICUs)" /><sentence text="" /><sentence text="This retrospective evaluation included patients who were admitted to the cardiac ICUs between January 2009 and July 2009 aged ≥ 18 years with electrocardiographic evidence of a QTc ≥ 500 ms" /><sentence text=" Patients receiving at least two concomitant drugs known to prolong the QT interval were considered to experience a pharmacodynamic DDI" /><sentence text=" Drugs causing CYP450 inhibition of the metabolism of QT prolonging medications were considered to cause pharmacokinetic DDIs" /><sentence text=" The causality between drug and QTc prolongation was evaluated with an objective scale" /><sentence text="" /><sentence text="One hundred eighty-seven patients experienced QT prolongation out of a total of 501 patients (37%) admitted during the study period" /><sentence text=" Forty-three percent and 47% of patients experienced 133 and 179 temporally-related pharmacodynamic and pharmacokinetic interactions, respectively" /><sentence text=" The most common medications related to these DDIs were ondansetron, amiodarone, metronidazole, and haloperidol"><entity charOffset="56-67" id="DDI-PubMed.23312127.s11.e0" text="ondansetron" /><entity charOffset="69-79" id="DDI-PubMed.23312127.s11.e1" text="amiodarone" /><entity charOffset="81-94" id="DDI-PubMed.23312127.s11.e2" text="metronidazole" /><entity charOffset="100-111" id="DDI-PubMed.23312127.s11.e3" text="haloperidol" /><pair ddi="false" e1="DDI-PubMed.23312127.s11.e0" e2="DDI-PubMed.23312127.s11.e0" /><pair ddi="false" e1="DDI-PubMed.23312127.s11.e0" e2="DDI-PubMed.23312127.s11.e1" /><pair ddi="false" e1="DDI-PubMed.23312127.s11.e0" e2="DDI-PubMed.23312127.s11.e2" /><pair ddi="false" e1="DDI-PubMed.23312127.s11.e0" e2="DDI-PubMed.23312127.s11.e3" /><pair ddi="false" e1="DDI-PubMed.23312127.s11.e1" e2="DDI-PubMed.23312127.s11.e1" /><pair ddi="false" e1="DDI-PubMed.23312127.s11.e1" e2="DDI-PubMed.23312127.s11.e2" /><pair ddi="false" e1="DDI-PubMed.23312127.s11.e1" e2="DDI-PubMed.23312127.s11.e3" /><pair ddi="false" e1="DDI-PubMed.23312127.s11.e2" e2="DDI-PubMed.23312127.s11.e2" /><pair ddi="false" e1="DDI-PubMed.23312127.s11.e2" e2="DDI-PubMed.23312127.s11.e3" /></sentence><sentence text="" /><sentence text="DDIs may be a significant cause of QT prolongation in cardiac ICUs" /><sentence text=" These data can be used to educate clinicians on safe medication use" /><sentence text=" Computerized clinical decision support could be applied to aid in the detection of these events" /><sentence text="" /></document>